Prevention of acute rejection after rescue with Belatacept by association of low-dose Tacrolimus maintenance in medically complex kidney transplant recipients with early or late graft dysfunction.
<h4>Background</h4>Increased acute rejection risk in rescue protocols with Belatacept may limit its use particularly in medically complex patients where preexisting increased risk of rejection couples with CNI toxicity.<h4>Methods</h4>Retrospective analysis was performed in 1...
Main Authors: | Ester Gallo, Isabella Abbasciano, Silvia Mingozzi, Antonio Lavacca, Roberto Presta, Stefania Bruno, Ilaria Deambrosis, Antonella Barreca, Renato Romagnoli, Alberto Mella, Fabrizio Fop, Luigi Biancone |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0240335 |
Similar Items
-
Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
by: Marieke van der Zwan, MD, et al.
Published: (2019-01-01) -
Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
by: Shruti Gupta, et al.
Published: (2018-01-01) -
Switch to belatacept in kidney graft recipients
by: María O. López-Oliva, et al.
Published: (2017-09-01) -
Switch to belatacept in kidney graft recipients
by: María O. López-Oliva, et al.
Published: (2017-09-01) -
CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
by: Marcos V. Silva, et al.
Published: (2012-01-01)